Literature DB >> 15135682

Criteria for establishing the adequacy of a sentinel lymphadenectomy.

Mona Duncan1, Amy Cech, Debra Wechter, Ravi Moonka.   

Abstract

BACKGROUND: Criteria are needed that could be used to terminate a sentinel lymphadenectomy for breast cancer prior to removing every sentinel lymph node, without increasing false negative rates.
METHODS: Quantitative information on the radioactivity and color of sentinel lymph nodes removed from 541 breast cancer patients was correlated with pathologic information to determine when a sentinel lymphadenectomy could be terminated based on characteristics of the initially removed nodes.
RESULTS: Tumor was found in the first two sentinel lymph nodes removed in 127 of 129 node-positive patients. In 65% of patients who were able to be evaluated, the most radioactive lymph node was a positive lymph node. When any axillary lymph node was blue, then the first tumor-containing sentinel lymph node was also blue.
CONCLUSIONS: Removal of the most radioactive lymph node does not insure accurate assessment of the axilla. Removal of two sentinel lymph nodes accurately staged 98.4% of node-positive patients and 99.6% of the entire study population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135682     DOI: 10.1016/j.amjsurg.2004.01.017

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer.

Authors:  Robert C G Martin; Anees Chagpar; Charles R Scoggins; Michael J Edwards; Lee Hagendoorn; Arnold J Stromberg; Kelly M McMasters
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

2.  Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer.

Authors:  Melanie A Lynch; Jeshaun Jackson; Julian A Kim; Rosemary A Leeming
Journal:  Surgery       Date:  2008-08-10       Impact factor: 3.982

3.  Clinical efficacy and problems with CT lymphography in identifying the sentinel node in breast cancer.

Authors:  Masako Takahashi; Mitsunori Sasa; Chieko Hirose; Sonoka Hisaoka; Masako Taki; Toshiyuki Hirose; Yoshimi Bando
Journal:  World J Surg Oncol       Date:  2008-06-12       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.